Skip to content

Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure.

Gastrointestinal (GI) symptoms are common in patients with chronic renal failure. Patients with chronic renal failure on dialysis have a high consumption of proton pump inhibitors (PPIs) and long-term treatment is very common. The aim of the study was to investigate the prevalence of gastroesophageal reflux symptoms (GORS), dyspeptic symptoms, and PPI treatment in patients with chronic renal failure on dialysis and to compare the impact of the different types of dialysis on these upper GI symptoms and PPI treatment.

Over five years, 15 percent of PPI users were diagnosed with chronic kidney disease, versus 11 percent of those on H2-blockers. After the researchers weighed other factors, PPI users still had a 28 percent greater risk. So, he said, people should first make sure they have true gastroesophageal reflux disease (GERD) — where stomach acids chronically rise up into the esophagus because of weakness in a muscle between the esophagus and stomach. It’s possible that the drug users suffer chronic kidney disease more often because they have overall poorer health, he said.

This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN.

If someone has inflammation in the esophagus or an ulcer, for instance, PPIs can allow those problems to heal, he explained. The researchers did try to rule out other possible explanations, such as PPI users being older or in poorer health.

Another study of 61 PD patients found that the incidence of GERD was not correlated with elevated daytime or nighttime intraperitoneal pressure (5). But a new study evaluating the use of PPIs in 125,000 patients indicates that more than half of patients who develop chronic kidney damage while taking the drugs don’t experience acute kidney problems beforehand, meaning patients may not be aware of a decline in kidney function, according to researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care System.

Our literature review from pub med revealed 8 studies investigating the differences between these two groups of patients (Table 5). The general feeling was that PD patients were more likely to get reflux symptoms [10-14]. HD patients, on the other hand had more constipation [10,14] and abdominal pain [8,15]. This study confirmed the association of abdominal pain with HD, but not other symptoms.

Untreated GERD can cause serious complications over time, including severe irritation of the esophagus from refluxed stomach acid that damages the lining and causes bleeding or ulcers (esophagitis). Adults who have chronic esophagitis over many years are more likely to develop precancerous changes in the esophagus.

  • The aim of the study was to investigate the prevalence of gastroesophageal reflux symptoms (GORS), dyspeptic symptoms, and PPI treatment in patients with chronic renal failure on dialysis and to compare the impact of the different types of dialysis on these upper GI symptoms and PPI treatment.
  • Almost three-quarters of patients who had a hip fracture had used the medications in the 3 years preceding their event.
  • Methods.

Gastroesophageal reflux disease is a common upper gastrointestinal disorder in chronic kidney disease. But, little is known about the prevalence in dialysis patients. The aims of this study were to determine the prevalence of GERD among chronic kidney disease with peritoneal dialysis and hemodialysis in Korea. Background. Patients with chronic renal failure (CRF) have a high prevalence of gastrointestinal symptoms.

World Journal of Gastroenterology. “What affects the gastrointestinal symptoms in peritoneal dialysis patients?.” ScienceDaily. www.sciencedaily.com/releases/2010/06/100624104528.htm (accessed September 23, 2019).

GERD (gastroesophageal reflux disease) is a chronic form of heartburn. Learn about symptoms and treatment. Washington, DC (September 27, 2018) – Certain medications commonly used to treat heartburn, acid reflux, and ulcers are linked with higher bone fracture risks among patients on dialysis, according to a new study.

In an independent study published by the medical journal CMAJ Open in April 2015, researchers found that users of PPI medications were three times more likely to suffer acute interstitial nephritis, which involves inflammation of the kidney. In addition, the study found that users were 2.5 times more likely to develop acute kidney injury, which involves an abrupt loss of kidney function. Nexium (esomeprazole) is one of the most recognized brand-name medications on the market in the United States, prescribed to millions of Americans for treatment of heartburn and acid reflux. It is part of a larger class of medications, known as proton pump inhibitors (PPIs), which also includes the blockbuster treatments Prilosec, Protonix, Prevacid, Dexilant and others.

This is an important differentiation. It’s possible that patients who are destined to have CKD get more heartburn and stomach problems. This would mean that there are other causes of CKD in users of PPIs. Antacids, like calcium carbonate (Tums), sodium bicarbonate, Maalox and Milk of Magnesia, relieve indigestion and heartburn by neutralising the acid in your stomach. They give quick relief that lasts for a few hours.

Antral gastritis was more common in the Helicobacter-positive than in the Helicobacter-negative renal patients (P less than 0.01), but the incidence of body gastritis did not differ between them. The Helicobacter-positive patients had lower serum urea levels (P less than 0.01) and higher acid outputs (P less than 0.001) than Helicobacter-negative subjects. All patients had raised fasting serum gastrin levels, which possibly obscured the difference between Helicobacter-positive (283 pg/ml) and -negative (331 pg/ml) patients. We conclude that in chronic renal failure gastric colonization of Helicobacter pylori is not more frequent than usual.

dialysis and acid reflux

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *